← SynDRA
BASIMGLURANT
SynDRA canonical compound SYN0038052 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GRM5 |
|---|
| Mechanism of action | Glutamate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Glutamate receptor antagonist
- GRM5 MODULATOR
- Metabotropic glutamate receptor 5 modulator
- GRM5 NEGATIVE ALLOSTERIC MODULATOR
- GRM5 ANTAGONIST
Cross-references
Synonyms
- Rg7090
- NOE-101
- RG-7090
- RO-4917523
- RO4917523
- RO4917523-000
- RO4917523-009 SULPHATE
- Antidepressant (oral), Hoffmann-La Roche
- MGluR5 antagonist (depression/fragile X syndrome, oral), Roche
- RG 7090
- Ro4917523
- RO 4917523
- basimglurantum
- RefChem:916723
- DTXCID801509996
- CTEP Derivative
- RG7090
- MFCD25976719
- C18H13ClFN3
- Basimglurant [USAN:INN]
- UNII-3110E3AO8S
- Basimglurant [INN]
- RG7090Basimglurant
- RG7090Basimglurant?
- Basimglurant (USAN/INN)
- BASIMGLURANT [USAN]
- BASIMGLURANT [WHO-DD]
- Basimglurant, RO4917523
- SCHEMBL560590
- GTPL9309
- orb1309164
- SCHEMBL29377966
- UPZWINBEAHDTLA-UHFFFAOYSA-N
- GLXC-90138
- HMS3741C15
- EX-A9888
- BDBM50071374
- EBC-48128
Look up BASIMGLURANT in the interactive SynDRA portal →